PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-107.38%
Both yoy net incomes decline, with CNQ at -169.80%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.99%
Less D&A growth vs. CNQ's 61.19%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-125.89%
Negative yoy deferred tax while CNQ stands at 70.59%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-98.96%
Both reduce yoy usage, with CNQ at -174.12%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-98.96%
Negative yoy usage while CNQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
183.36%
Lower 'other non-cash' growth vs. CNQ's 1650.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-30.64%
Both yoy CFO lines are negative, with CNQ at -5.41%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
23.31%
Some CapEx rise while CNQ is negative at -114.68%. John Neff would see competitor possibly building capacity while we hold back expansions.
-292.73%
Negative yoy acquisition while CNQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Negative yoy purchasing while CNQ stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
We reduce yoy sales while CNQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
97.30%
Growth well above CNQ's 21.84%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-44.94%
Both yoy lines negative, with CNQ at -124.97%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment above 1.5x CNQ's 65.90%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.